EUCTR2012-002819-26-IT进行中（未招募）不适用
FMISO F18 PET/CT as marker of hypoxia in patients undergoing radio- and chemotherapy - FMISO PET/CT in tumours
CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA0 个研究点开始时间: 2012年10月25日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients for whom is mandatory to assess the hypoxia and to monitor therapy efficay early
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 70
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Age <18 yrs. o >90 yrs
研究者
相似试验
已完成
1 期
Clinical Evaluation of the New Hypoxia Imaging Agent HX4Head and Neck CancerLung CancerLiver CancerNCT01213030Siemens Molecular Imaging12
已完成
不适用
Tumor hypoxia measured with F-MISO-PET in the course of irradiation of head and neck cancer: adoption of the method into clinical routine and evaluation of the dataC10C13Malignant neoplasm of oropharynxMalignant neoplasm of hypopharynxDRKS00006007niversitätsklinikum DresdenKlinik für Strahlentherapie und Radioonkologie59
已完成
1 期
Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung CancerNon-small Cell Lung CancerNCT01017133Abramson Cancer Center at Penn Medicine56
招募中
不适用
FAZA PETMRI Gastro-Oesophageal StudyMetastasized Gastro-Oesophageal CancerNCT04560036University Health Network, Toronto40
已完成
不适用
Hypoxia imaging with 18F-Misonidazole PET in brain metastasismetastatic brain tumorJPRN-UMIN000014572Departments of Radiation Oncology, Hokkaido University Hospital25